中国神经再生研究(英文版) ›› 2018, Vol. 13 ›› Issue (7): 1204-1211.doi: 10.4103/1673-5374.232476

• 原著:脑损伤修复保护与再生 • 上一篇    下一篇

银杏内酯B诱导脑缺血再灌注损伤大鼠神经干细胞增殖和分化的体内外实验

  

  • 收稿日期:2018-03-05 出版日期:2018-07-15 发布日期:2018-07-15
  • 基金资助:

    中国国家自然科学基金项目(81073082

Ginkgolide B promotes the proliferation and differentiation of neural stem cells following cerebral ischemia/reperfusion injury, both in vivo and in vitro

Pei-Dong Zheng, Rajneesh Mungur, Heng-Jun Zhou, Muhammad Hassan, Sheng-Nan Jiang, Jie-Sheng Zheng   

  1. Department of Neurosurgery, the First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China
  • Received:2018-03-05 Online:2018-07-15 Published:2018-07-15
  • Contact: Jie-Sheng Zheng, M.D., Ph.D.,zhengjiesheng@zju.edu.cn.
  • Supported by:

    This work was supported by the National Natural Science Foundation of China, No. 81073082 to JSZ.

摘要:

中枢神经系统中的神经干细胞虽具有治疗某些神经系统疾病的潜力,但是来源于脑缺血部位的内源性神经干细胞的增殖能力不足应对自我修复损伤的中枢神经系统,而银杏内酯B具有明显的神经保护作用,实验拟探索银杏内酯B对局灶性脑缺血再灌注损伤神经保护作用的机制。首先进行体外实验,神经干细胞分别经20,40,60 mg/L银杏内酯B干预,观察细胞形态变化,并使用免疫荧光染色检测细胞中神经元特异性烯醇化酶、胶质纤维酸性蛋白和细胞因子信号传导抑制因子2阳性细胞。结果显示40和60mg/L银杏内酯B干预培养的神经干细胞突起更长,且细胞体积更大,且40mg/L银杏内酯B干预的细胞中神经元特异性烯醇化酶、胶质纤维酸性蛋白和细胞因子信号传导抑制因子2阳性细胞比例增加。然后进行体内实验,以大脑中动脉闭塞法建立脑缺血再灌注损伤大鼠模型后,于缺血后6h起,腹腔注射20mg/kg银杏内酯B,1次/d。以Zea Longa方法评估神经功能,免疫组化方法检测神经干细胞标志物巢蛋白、神经元标志物神经元特异性烯醇酶及星形胶质细胞标志物胶质纤维酸蛋白阳性细胞比例,实时荧光PCR检测2种神经营养因子脑源性神经营养因子和表皮生长因子mRNA表达,Western blot分析脑源性神经营养因子及细胞因子信号传导抑制因子2表达水平。结果显示经银杏内酯B治疗后,脑缺血再灌注损伤大鼠神经功能缺损评分降低,缺血半暗带中巢蛋白、神经元特异性烯醇酶及胶质纤维酸蛋白阳性细胞比例增加,缺血半暗带中脑源性神经营养因子和表皮生长因子mRNA的表达增加,缺血半暗带中脑源性神经营养因子和细胞因子信号传导抑制因子2蛋白表达增加。体内外实验数据证实,银杏内酯B可通过促进神经干细胞的增殖和分化,改善脑缺血再灌注损伤大鼠的神经功能。

orcid:0000-0001-9411-2879(Jie-Sheng Zheng)

关键词: 神经再生, 脑源性神经营养因子, 表皮生长因子, 细胞因子信号传导抑制因子2, 神经元特异性烯醇酶, 胶质纤维酸蛋白, 巢蛋白, BrU, 神经功能, 大脑中动脉闭塞, 星形胶质细胞

Abstract:

Neural stem cells have great potential for the development of novel therapies for nervous system diseases. However, the proliferation of endogenous neural stem cells following brain ischemia is insufficient for central nervous system self-repair. Ginkgolide B has a robust neuroprotective effect. In this study, we investigated the cell and molecular mechanisms underlying the neuroprotective effect of ginkgolide B on focal cerebral ischemia/reperfusion injury in vitro and in vivo. Neural stem cells were treated with 20, 40 and 60 mg/L ginkgolide B in vitro. Immunofluorescence staining was used to assess cellular expression of neuron-specific enolase, glial fibrillary acid protein and suppressor of cytokine signaling 2. After treatment with 40 and 60 mg/L ginkgolide B, cells were large, with long processes. Moreover, the proportions of neuron-specific enolase-, glial fibrillary acid protein- and suppressor of cytokine signaling 2-positive cells increased. A rat model of cerebral ischemia/reperfusion injury was established by middle cerebral artery occlusion. Six hours after ischemia, ginkgolide B (20 mg/kg) was intraperitoneally injected, once a day. Zea Longa’s method was used to assess neurological function. Immunohistochemistry was performed to evaluate the proportion of nestin-, neuron-specific enolase- and glial fibrillary acid protein-positive cells. Real-time quantitative polymerase chain reaction was used to measure mRNA expression of brain-derived neurotrophic factor and epidermal growth factor. Western blot assay was used to analyze the expression levels of brain-derived neurotrophic factor and suppressor of cytokine signaling 2. Ginkgolide B decreased the neurological deficit score, increased the proportion of nestin-, neuron-specific enolase- and glial fibrillary acid protein-positive cells, increased the mRNA expression of brain-derived neurotrophic factor and epidermal growth factor,and increased the expression levels of brain-derived neurotrophic factor and suppressor of cytokine signaling 2 in the ischemic penumbra.Together, the in vivo and in vitro findings suggest that ginkgolide B improves neurological function by promoting the proliferation and differentiation of neural stem cells in rats with cerebral ischemia/reperfusion injury.

Key words: nerve regeneration, brain-derived neurotrophic factor, epidermal growth factor, suppressor of cytokine signaling 2, neuron-specific enolase, glial fibrillary acid protein, nestin, bromodeoxyuridine, neurological function, middle cerebral artery occlusion, astrocytes, neural regeneration